Note 4 - Stock Options and Warrants (Details 1) |
9 Months Ended |
|---|---|
|
Sep. 30, 2020
$ / shares
shares
| |
| Equity [Abstract] | |
| Outstanding, beginning | shares | 1,813,053 |
| Granted | shares | 6,500 |
| Forfeited | shares | 480,352 |
| Exercised | shares | 0 |
| Outstanding, ending | shares | 7,832,701 |
| Exercisable | shares | 7,832,701 |
| Outstanding, beginning | $ / shares | $ 0.20 |
| Granted | $ / shares | .20 |
| Forfeited | $ / shares | .20 |
| Exercised | $ / shares | .00 |
| Outstanding, ending | $ / shares | .20 |
| Exercisable | $ / shares | $ .20 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|